Previous close | 213.97 |
Open | 214.87 |
Bid | 218.78 x 1200 |
Ask | 260.00 x 800 |
Day's range | 213.82 - 219.32 |
52-week range | 203.37 - 460.21 |
Volume | |
Avg. volume | 556,849 |
Market cap | 11.118B |
Beta (5Y monthly) | 1.27 |
PE ratio (TTM) | 26.67 |
EPS (TTM) | 8.20 |
Earnings date | 02 Aug 2022 - 08 Aug 2022 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 327.64 |
Charles River's (CRL) industry knowledge in plasmid DNA production will benefit Ziphius Vaccines' early-stage saRNA manufacturing program.
It is hard to get excited after looking at Charles River Laboratories International's (NYSE:CRL) recent performance...
WILMINGTON, Mass. & MACCLESFIELD, England, June 28, 2022--Charles River announces the opening of their High Quality Plasmid DNA Centre of Excellence at Bruntwood SciTech’s Alderley Park.